Improving the evaluation and diagnosis of clinically significant prostate cancer

Oleksandr Kryvenko, Jonathan I. Epstein

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Purpose of review This chapter describes important changes in the clinical practice and pathological interpretation of prostate cancer (PCa) that stratify PCa into insignificant and significant disease to allow for better patient management and treatment decisions. Recent findings Among the most important changes over the last half a decade has been the change in PCa grading. A new grading system has been developed that is more patient-centric with more accurate stratification according to risk of disease progression. An additional advance is the recent recommendation to report percentage of pattern 4 in Gleason score 7 cancer that may help identify a subset of these men who have relatively insignificant prostate cancer. The definition of significant PCa at prostatectomy has also been extended from a dichotomized classification into a more tiered nuanced approach. Factors involved in classification of significant cancer at prostatectomy include grade, stage along with classification of extraprostatic extension into focal and nonfocal, and tumor volume. Of these variables, tumor volume appears to be least critical as an independent variable. Promising genetic discoveries may also help predict significant cancer, especially in the small subset of lower-grade cancers. Summary Significant PCa is a spectrum of findings bearing different clinical significance with some nuanced definitions at biopsy and prostatectomy.

Original languageEnglish (US)
Pages (from-to)191-197
Number of pages7
JournalCurrent Opinion in Urology
Volume27
Issue number3
DOIs
StatePublished - May 1 2017

Fingerprint

Prostatic Neoplasms
Prostatectomy
Tumor Burden
Neoplasms
Neoplasm Grading
Disease Progression
Biopsy

Keywords

  • Grade Group
  • prostate cancer
  • significant

ASJC Scopus subject areas

  • Urology

Cite this

Improving the evaluation and diagnosis of clinically significant prostate cancer. / Kryvenko, Oleksandr; Epstein, Jonathan I.

In: Current Opinion in Urology, Vol. 27, No. 3, 01.05.2017, p. 191-197.

Research output: Contribution to journalReview article

@article{80803c5dac684622b34c4ab42cd2b329,
title = "Improving the evaluation and diagnosis of clinically significant prostate cancer",
abstract = "Purpose of review This chapter describes important changes in the clinical practice and pathological interpretation of prostate cancer (PCa) that stratify PCa into insignificant and significant disease to allow for better patient management and treatment decisions. Recent findings Among the most important changes over the last half a decade has been the change in PCa grading. A new grading system has been developed that is more patient-centric with more accurate stratification according to risk of disease progression. An additional advance is the recent recommendation to report percentage of pattern 4 in Gleason score 7 cancer that may help identify a subset of these men who have relatively insignificant prostate cancer. The definition of significant PCa at prostatectomy has also been extended from a dichotomized classification into a more tiered nuanced approach. Factors involved in classification of significant cancer at prostatectomy include grade, stage along with classification of extraprostatic extension into focal and nonfocal, and tumor volume. Of these variables, tumor volume appears to be least critical as an independent variable. Promising genetic discoveries may also help predict significant cancer, especially in the small subset of lower-grade cancers. Summary Significant PCa is a spectrum of findings bearing different clinical significance with some nuanced definitions at biopsy and prostatectomy.",
keywords = "Grade Group, prostate cancer, significant",
author = "Oleksandr Kryvenko and Epstein, {Jonathan I.}",
year = "2017",
month = "5",
day = "1",
doi = "10.1097/MOU.0000000000000388",
language = "English (US)",
volume = "27",
pages = "191--197",
journal = "Current Opinion in Urology",
issn = "0963-0643",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Improving the evaluation and diagnosis of clinically significant prostate cancer

AU - Kryvenko, Oleksandr

AU - Epstein, Jonathan I.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Purpose of review This chapter describes important changes in the clinical practice and pathological interpretation of prostate cancer (PCa) that stratify PCa into insignificant and significant disease to allow for better patient management and treatment decisions. Recent findings Among the most important changes over the last half a decade has been the change in PCa grading. A new grading system has been developed that is more patient-centric with more accurate stratification according to risk of disease progression. An additional advance is the recent recommendation to report percentage of pattern 4 in Gleason score 7 cancer that may help identify a subset of these men who have relatively insignificant prostate cancer. The definition of significant PCa at prostatectomy has also been extended from a dichotomized classification into a more tiered nuanced approach. Factors involved in classification of significant cancer at prostatectomy include grade, stage along with classification of extraprostatic extension into focal and nonfocal, and tumor volume. Of these variables, tumor volume appears to be least critical as an independent variable. Promising genetic discoveries may also help predict significant cancer, especially in the small subset of lower-grade cancers. Summary Significant PCa is a spectrum of findings bearing different clinical significance with some nuanced definitions at biopsy and prostatectomy.

AB - Purpose of review This chapter describes important changes in the clinical practice and pathological interpretation of prostate cancer (PCa) that stratify PCa into insignificant and significant disease to allow for better patient management and treatment decisions. Recent findings Among the most important changes over the last half a decade has been the change in PCa grading. A new grading system has been developed that is more patient-centric with more accurate stratification according to risk of disease progression. An additional advance is the recent recommendation to report percentage of pattern 4 in Gleason score 7 cancer that may help identify a subset of these men who have relatively insignificant prostate cancer. The definition of significant PCa at prostatectomy has also been extended from a dichotomized classification into a more tiered nuanced approach. Factors involved in classification of significant cancer at prostatectomy include grade, stage along with classification of extraprostatic extension into focal and nonfocal, and tumor volume. Of these variables, tumor volume appears to be least critical as an independent variable. Promising genetic discoveries may also help predict significant cancer, especially in the small subset of lower-grade cancers. Summary Significant PCa is a spectrum of findings bearing different clinical significance with some nuanced definitions at biopsy and prostatectomy.

KW - Grade Group

KW - prostate cancer

KW - significant

UR - http://www.scopus.com/inward/record.url?scp=85017504810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017504810&partnerID=8YFLogxK

U2 - 10.1097/MOU.0000000000000388

DO - 10.1097/MOU.0000000000000388

M3 - Review article

C2 - 28376512

AN - SCOPUS:85017504810

VL - 27

SP - 191

EP - 197

JO - Current Opinion in Urology

JF - Current Opinion in Urology

SN - 0963-0643

IS - 3

ER -